Genmab A/S buy tbackenh
Start price
14.03.14
/
50%
€31.91
Target price
18.03.14
€37.50
Performance (%)
0.00%
End price
18.03.14
€31.91
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Genmab A/S | -6.554% | -6.554% | 5.925% | -32.047% |
| iShares Core DAX® | -6.016% | -4.595% | 1.274% | 48.617% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.573% | 86.131% |
| iShares Nikkei 225® | -7.156% | -2.215% | 28.107% | 53.169% |
| iShares S&P 500 | -0.257% | -0.841% | 10.196% | 58.399% |
Comments by tbackenh for this prediction
In the thread Genmab A/S diskutieren
Genmab AS
Biotechnologie aus dem Nachbarland Dänemark! Trotz der relativ kleinen Marktkapitalisierung ein interessanter Wert mit guten Wachstumsaussichten.